-
Second FDA Response Letter Issued for ND0612 Therapy
February 3, 2026
… medication under the skin rather than through the digestive system bypasses the stomach, potentially helping maintain … steadier symptom control. ND0612 is one of several infusion systems that have been considered for FDA approval in the …
-
Genetic and Environmental Modifiers for LRRK2-Associated PD
… risk and phenotype might depend on the co-occurrence of multiple genes and environmental exposures. However, …
-
NH004 Films for Sialorrhea in PD Patients (2011)
… Crossover Pilot Study of the Safety and Efficacy of Multiple Doses of Intra-oral Tropicamide Films for the …
-
Elucidating the Function and Downstream Targets of LRRK2
… kinase activity. By examining putative LRRK2 substrates in multiple cell types, as well as in vivo using PD model …
-
Modelling LRRK2 Structure and Characterizing the LRRK2 Activation Cycle in LRRK2-mediated Parkinson's disease
… the resulting model suggests compact folding of LRRK2 with multiple domain-domain contacts (how a protein is …
-
Advancement/Special Events Intern
… • Phone number verification in Spokeo so we’re not calling multiple numbers (for new donors/prospects) • Printing …
Animations
Your search for “Multiple System Atrophy” returned 2623 results.